Cargando…
Relaxin Does Not Improve Angiotensin II-Induced Target-Organ Damage
Relaxin is a corpus-luteum produced protein hormone with vasodilatatory, anti-fibrotic, and angiogenic properties that are opposite to angiotensin (Ang) II. We investigated whether or not relaxin ameliorates Ang II-induced target-organ damage. We used double transgenic rats harboring both human reni...
Autores principales: | Haase, Nadine, Rugor, Julianna, Przybyl, Lukasz, Qadri, Fatimunnisa, Müller, Dominik N., Dechend, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977876/ https://www.ncbi.nlm.nih.gov/pubmed/24710077 http://dx.doi.org/10.1371/journal.pone.0093743 |
Ejemplares similares
-
Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat Model
por: Haase, Nadine, et al.
Publicado: (2016) -
Vitamin D Depletion Aggravates Hypertension and Target‐Organ Damage
por: Andersen, Louise Bjørkholt, et al.
Publicado: (2015) -
α(1A)-Adrenergic Receptor-Directed Autoimmunity Induces Left Ventricular Damage and Diastolic Dysfunction in Rats
por: Wenzel, Katrin, et al.
Publicado: (2010) -
Angiotensin-(1–7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice
por: Järve, Anne, et al.
Publicado: (2020) -
Effects of empagliflozin and target-organ damage in a novel rodent model of heart failure induced by combined hypertension and diabetes
por: Kräker, Kristin, et al.
Publicado: (2020)